55 results
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
procedures (subject to the record retention requirement of the Exchange Act and the Trustee) and deliver a certificate of such cancellation
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
to each Issuer Free Writing Prospectus including, without limitation, all prospectus delivery, filing, record retention and legending requirements … and commercially reasonable security controls regarding the collection, use, disclosure, retention, confidentiality, integrity, and availability of personal
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any
424B5
n76jtdpqgl2cg6cjfdb4
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
vf9ma1as
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
nzdouogkg3xuk
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
hw3oy6zxvei
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
bd21h8mj mykl1u0ps
28 Mar 22
Prospectus supplement for primary offering
4:53pm